OBJECTIVES

This study aimed to describe how the current practice of peripherally inserted central catheter (PICC) use in hospitalized children aligns with the Michigan Appropriateness Guide for Intravenous Catheters (miniMAGIC) in Children recommendations, explore variation across sites, and describe the population of children who do not receive appropriate PICCs.

METHODS

A retrospective study was conducted at 4 children’s hospitals in the United States. Children with PICCs placed January 2019 to December 2021 were included. Patients in the NICU were excluded. PICCs were categorized using the miniMAGIC in Children classification as inappropriate, uncertain appropriateness and appropriate.

RESULTS

Of the 6051 PICCs identified, 9% (n = 550) were categorized as inappropriate, 9% (n = 550) as uncertain appropriateness, and 82% (n = 4951) as appropriate. The number of PICCs trended down over time, but up to 20% of PICCs each year were not appropriate, with significant variation between sites. Within inappropriate or uncertain appropriateness PICCs (n = 1100 PICC in 1079 children), median (interquartile range) patient age was 4 (0–11) years, 54% were male, and the main reason for PICC placement was prolonged antibiotic course (56%, n = 611). The most common admitting services requesting the inappropriate/uncertain appropriateness PICCs were critical care 24%, general pediatrics 22%, and pulmonary 20%. Complications resulting in PICC removal were identified in 6% (n = 70) of inappropriate/uncertain PICCs. The most common complications were dislodgement (3%) and occlusion (2%), with infection and thrombosis rates of 1% (n = 10 and n = 13, respectively).

CONCLUSIONS

Although the majority of PICCs met appropriateness criteria, a substantial proportion of PICCs were deemed inappropriate or of uncertain appropriateness, illustrating an opportunity for quality improvement.

Peripherally inserted central catheters (PICCs) are vascular access devices generally inserted in the upper extremity, with the tip ending in the central circulation, preferably at the junction of the superior vena cava and the right atrium. PICCs are frequently used in hospitalized children for prolonged vascular access or to administer solutions not compatible with peripheral infusion. However, concerns regarding potentially inappropriate use (harm outweighing the benefit) of PICCs are reported in both adults and children.13  PICCs are associated with serious complications such as central line-associated blood stream infections (CLABSI) and venous thromboembolism (VTE),4  so identifying situations when PICCs could be avoided is critical.

The Michigan Appropriateness Guide for Intravenous (IV) Catheters in Pediatrics (miniMAGIC), was developed and published in June 2020 in accordance with the Rand/University of California, Los Angeles, appropriateness method, balancing the best available evidence with expert judgment to form a statement regarding device selection and placement/insertion. The miniMAGIC guideline suggests that patients needing vascular access for ≤14 days for therapies that are peripherally compatible may be better served with a peripheral catheter (eg, midline catheter, peripheral IV catheter) instead of a PICC.57  On the basis of the length of use and therapies provided, the miniMAGIC guideline classifies each vascular access device as appropriate, inappropriate, or of uncertain appropriateness.

The purpose of this study was to describe how the current practice of PICC use in hospitalized children aligns with miniMAGIC recommendations by determining the percentage of PICCs placed within the past few years that were appropriate, inappropriate, or of uncertain appropriateness. We also aimed to compare differences in appropriateness across the different participating sites, and further describe the population of children who receive uncertain appropriateness or inappropriate PICCs. Understanding the current practice of PICC utilization is the first fundamental step in improving the quality of care and safety of hospitalized children in need of reliable vascular access. Identifying situations in which PICCs are used inappropriately will allow us to develop specific interventions to reduce unnecessary PICC placement.

This multisite, retrospective cohort study was a collaborative effort between 4 pediatric medical centers representing the Midwest and Southeast regions of the United States and has been reported in alignment with the Strengthening the Reporting of Observational Studies in Epidemiology Guidelines.8  Two of the medical centers are medium size (200–400 beds), 1 small (<200 beds), and 1 large (>400 beds). All 4 sites are standalone children’s hospitals affiliated with a medical school. The study cohort included all PICCs placed in hospitalized children aged <18 years between January 2019 and December 2021. PICCs placed in patients admitted to the NICU were excluded, as per the scope of miniMAGIC guidance.

The population of interest was identified using electronic medical record (EMR)-based databases at each participating institution. Encounters with PICCs were identified using the line/drain/airway section of the EMR. Measures unavailable in the database were collected manually via retrospective chart review. To ensure consistency and accuracy in data collection and recording, a detailed protocol with clear definitions and directions was developed. Each collected variable had predetermined answer choices. Because only deidentified data were harmonized by the coordinating center, the institutional review board at each site deemed the study as exempt.

Assessment of PICC Appropriateness and Trends

PICC utilization trends were assessed over time, pre and post-miniMAGIC guideline, and between sites using the proportion of total PICCs placed over the total inpatient encounters that satisfied the inclusion/exclusion criteria. All PICCs from the identified cohort were classified as appropriate, inappropriate, or uncertain appropriateness on the basis of dwell time, type of infusate (peripheral compatible or not), and continuation at discharge. Definitions are presented in Fig 1.

FIGURE 1

Definitions of the 3 appropriateness groups of PICCs based on the miniMAGIC guide.

FIGURE 1

Definitions of the 3 appropriateness groups of PICCs based on the miniMAGIC guide.

Close modal

Patient and PICC Characteristics Variables

A more detailed analysis was performed for the patients with PICCs in the inappropriate and uncertain appropriateness groups. Variables were selected on the basis of established best practices.9,10  The following characteristics of the patient and clinical encounter were collected: demographic data, existence of chronic complex conditions, service requesting the PICC, primary diagnostic category (medical versus surgical, infectious versus noninfectious), and patient location (eg, intensive care, acute care). PICC data collected included main reason for PICC placement, use for blood draws, number of lumens, inserter type (eg, physician, nurse), insertion vessel, number of attempts, dwell time, reason for removal, and catheter-associated complications (VTE, CLABSI, concern for VTE, concern for CLABSI, infiltration, dislodgement, phlebitis, occlusion, line dysfunction/fracture).

Definitions of Catheter-Associated Complications

Definitions for catheter-associated complications were based on national and international benchmarks that could be pragmatically applied to a retrospective chart audit. A catheter-associated VTE was defined as ultrasound finding of thrombus at the catheter site.11  Concern for VTE was defined as obtaining an ultrasound to evaluate for catheter-related thrombus that was negative. CLABSI was defined using the National Healthcare Safety Network surveillance definition of a laboratory-confirmed infection where a PICC was in place for >2 calendar days before a positive blood culture, and was also in place the day of or the day before the positive culture.12  Concern for CLABSI was defined as a negative blood culture obtained while the catheter was in place. Additional catheter-associated complications such as infiltrations, phlebitis, and line dysfunction could not be objectively defined because of the limitation of the retrospective nature of the study and the reliance on existing EMR documentation.

Descriptive statistics were used to report patient and catheter characteristics, with PICCs being the primary unit of analysis. Continuous variables were summarized using median and interquartile range, whereas categorical variables were summarized as n (%). The Cochran-Mantel-Haenszel test was used to compare differences in appropriateness over time and between institutions. Interrupted time series analysis was used to compare the rates of inappropriate PICCs by month pre and post-miniMAGIC guideline. A P value < .05 was considered significant. SPSS version 28.0 (IBM Corp., Armonk, New York), SAS version 9.4 (SAS Institute Inc., Cary, North Carolina), and R13  were used for statistical analysis.

A total of 6051 PICCs were placed during the study period at the participating sites. The rate of PICC use decreased overtime; however, 16% to 20% of the PICCs placed each year were uncertain or inappropriate (Fig 2A). Over the 3-year study period, 9% (n = 550) of total PICCs were inappropriate and 9% (n = 550) were of uncertain appropriateness. Significant difference in PICC appropriateness was noted between years, P = .042, and between sites, P < .0001 (Fig 2B). The difference in appropriateness between years and sites remained significant (P = .025 and < .0001, respectively) after removing the PICCs in the inappropriate and uncertain groups that were placed in children that had:

FIGURE 2

Trends (2A) and variation (2B) in PICC appropriateness at the participating sites between 2019 and 2021. (2C) Use of inappropriate PICCs pre and post-miniMAGIC.

FIGURE 2

Trends (2A) and variation (2B) in PICC appropriateness at the participating sites between 2019 and 2021. (2C) Use of inappropriate PICCs pre and post-miniMAGIC.

Close modal

1. >1 PICC during the same encounter (n = 21); or

2. those in which the PICC was removed early because of a complication (n = 70), assuming those cases may have been appropriate if a catheter-related complication never occurred.

When examining differences in inappropriate PICC use by month pre and post-miniMAGIC guideline (Fig 2C), we found a 22% decrease in use; however, the decrease was not statistically significant (relative risk 0.78, 95% confidence interval [0.55–1.11], P = .17).

Patient and Encounter Characteristics

The inappropriate and uncertain appropriateness PICC groups included a total of 1100 PICCs placed in 1079 children. Median age of the children in the groups was 4 years (interquartile range 0–11); 54% were male (Table 1). Fifty-five percent had a complex medical condition, 79% had a primary medical diagnosis, and 64% were treated for an infection during their hospitalization. The most common services requesting the PICC were: 24% critical care, 22% general pediatrics, and 20% pulmonary (Table 2). The most common reason for placing the PICC was prolonged antibiotic course (56%), followed by durable access (30%). Of the children in both the inappropriate and uncertain appropriateness groups admitted to the general pediatrics or pediatric hospitalist service, 75% (185 of 247) used the PICC for prolonged antibiotic courses. The most common infections treated being meningitis/encephalitis (25%, 47 of 185), pneumonia (13%, 24 of 185), and joint and bone infections (12%, 23 of 185). The most common reason for placing a PICC by the critical care service was the need for durable access (53%, 139 of 264), followed by prolonged antibiotic courses (33%, 88 of 264), with pneumonia and meningitis/encephalitis remaining the 2 most treated infections (29% and 25%, respectively). Within the group of PICCs placed by pulmonary service, 92% (203 of 220) were placed for prolonged antibiotic courses and, within this group, 86% PICCs were for treatment of pulmonary exacerbation of cystic fibrosis. Within the group of patients who had a primary surgical diagnosis (21%, 227 of 1100), the most common service requesting a PICC was neurosurgery (28%, 63 of 227), and the most 2 common primary diagnoses for this group were ventriculoperitoneal shunt malfunction/infection and epilepsy.

TABLE 1

Patient Characteristics

Combined, N = 1079Inappropriate Group, N = 541Uncertain Appropriateness Group, N = 538
N EvalN (%) or Median (IQR)N EvalN (%) or Median (IQR)N EvalN (%) or Median (IQR)
Sites 1079  541  538  
 Site 1  260 (24)  131 (24)  129 (24) 
 Site 2  239 (22)  129 (24)  110 (20) 
 Site 3  168 (16)  95 (18)  73 (14) 
 Site 4  412 (38)  186 (34)  226 (42) 
1079  541  538  
 2019  446 (42)  229 (42)  217 (40) 
 2020  328 (30)  161 (30)  167 (31) 
 2021  305 (28)  151 (28)  154 (29) 
Age, y 1079 4 (0–11) 541 3 (0–10) 538 4 (0–11) 
Age group 1079  541  538  
 <1 y  318 (29)  149 (28)  169 (32) 
 1–11 y  516 (48)  278 (51)  238 (44) 
 12–18 y  245 (23)  114 (21)  131 (24) 
Sex 1079  541  538  
 Male  578 (54)  295 (55)  283 (53) 
 Female  501 (46)  246 (45)  255 (47) 
Race 1036  508  528  
 White  736 (71)  354 (70)  382 (73) 
 African American  241 (23)  118 (23)  123 (23) 
 Asian American  16 (2)  10 (2)  6 (1) 
 Multirace/other  43 (4)  26 (5)  17 (3) 
Ethnicity 1071  533  538  
 Hispanic  85 (8)  44 (8)  41 (8) 
 Non-Hispanic  986 (92)  489 (92)  497 (92) 
Complex chronic conditions 1079  541  538  
 No  487 (45)  254 (47)  233 (43) 
 Yes  592 (55)  287 (53)  305 (57) 
Combined, N = 1079Inappropriate Group, N = 541Uncertain Appropriateness Group, N = 538
N EvalN (%) or Median (IQR)N EvalN (%) or Median (IQR)N EvalN (%) or Median (IQR)
Sites 1079  541  538  
 Site 1  260 (24)  131 (24)  129 (24) 
 Site 2  239 (22)  129 (24)  110 (20) 
 Site 3  168 (16)  95 (18)  73 (14) 
 Site 4  412 (38)  186 (34)  226 (42) 
1079  541  538  
 2019  446 (42)  229 (42)  217 (40) 
 2020  328 (30)  161 (30)  167 (31) 
 2021  305 (28)  151 (28)  154 (29) 
Age, y 1079 4 (0–11) 541 3 (0–10) 538 4 (0–11) 
Age group 1079  541  538  
 <1 y  318 (29)  149 (28)  169 (32) 
 1–11 y  516 (48)  278 (51)  238 (44) 
 12–18 y  245 (23)  114 (21)  131 (24) 
Sex 1079  541  538  
 Male  578 (54)  295 (55)  283 (53) 
 Female  501 (46)  246 (45)  255 (47) 
Race 1036  508  528  
 White  736 (71)  354 (70)  382 (73) 
 African American  241 (23)  118 (23)  123 (23) 
 Asian American  16 (2)  10 (2)  6 (1) 
 Multirace/other  43 (4)  26 (5)  17 (3) 
Ethnicity 1071  533  538  
 Hispanic  85 (8)  44 (8)  41 (8) 
 Non-Hispanic  986 (92)  489 (92)  497 (92) 
Complex chronic conditions 1079  541  538  
 No  487 (45)  254 (47)  233 (43) 
 Yes  592 (55)  287 (53)  305 (57) 

Eval, evaluation; IQR, interquartile range.

TABLE 2

Encounter and PICC Characteristics

Combined, N = 1100Inappropriate Group, N = 550Uncertain Appropriateness Group, N = 550
N EvalN (%)N EvalN (%)N EvalN (%)
Service requesting PICC 1100  550  550  
 Critical care  264 (24)  146 (27)  118 (22) 
 General pediatric  247 (22)  125 (23)  122 (22) 
 Pulmonary  220 (20)  67 (12)  153 (28) 
 Gastroenterology  96 (9)  62 (11)  34 (6) 
 Neurosurgery  99 (9)  57 (10)  42 (8) 
 General surgery  36 (3)  28 (5)  8 (1) 
 Orthopedics  21 (2)  14 (2)  7 (1) 
 Cardiology  12 (1)  5 (1)  7 (1) 
 Other  105 (10)  46 (9)  59 (11) 
Patient location 1100  550  550  
 Acute care  761 (69)  356 (65)  405 (74) 
 Critical care  304 (28)  169 (31)  135 (24) 
 Other (eg, preoperative)  35 (3)  25 (4)  10 (2) 
Reason for PICC placement       
 Difficult access 1100 137 (12) 550 82 (15) 550 55 (10) 
 Durable access 1100 329 (30) 550 181 (33) 550 148 (27) 
 Frequent laboratory draws 1100 151 (14) 550 84 (15) 550 67 (12) 
 Prolonged antibiotic course 1100 611 (56) 550 254 (46) 550 357 (65) 
 Other reason 1100 45 (4) 550 33 (6) 550 12 (2) 
Number of lumens 1090  545  545  
 1  960 (88)  473 (87)  487 (89) 
 ≥2  130 (12)  72 (13)  58 (11) 
Operator type 1099  549  550  
 Physician  48 (4)  28 (5)  20 (4) 
 PA/NP  381 (35)  207 (38)  174 (32) 
 RN  670 (61)  314 (57)  356 (64) 
PICC insertion site/vessel 1091  544  547  
 Basilic  593 (54)  292 (54)  301 (55) 
 Brachial  177 (16)  83 (15)  94 (17) 
 Cephalic  106 (10)  49 (9)  57 (11) 
 Femoral  132 (12)  78 (14)  54 (10) 
 Other insertion site  83 (8)  42 (8)  41 (7) 
Number of attempts 1093  546  547  
 1  886 (81)  454 (83)  432 (79) 
 2  127 (12)  59 (11)  68 (13) 
 3  58 (5)  24 (4)  34 (6) 
 >3  22 (2)  9 (2)  13 (2) 
PICC used for blood draws? 695a 555 (80) 367 279 (76) 328 276 (84) 
Reason for removal 1096  549  547  
 No longer medically necessary  1009 (92)  494 (90)  515 (94) 
 Complications  70 (6)  41 (8)  29 (5) 
 Other reason  17 (2)  14 (2)  3 (<1) 
Combined, N = 1100Inappropriate Group, N = 550Uncertain Appropriateness Group, N = 550
N EvalN (%)N EvalN (%)N EvalN (%)
Service requesting PICC 1100  550  550  
 Critical care  264 (24)  146 (27)  118 (22) 
 General pediatric  247 (22)  125 (23)  122 (22) 
 Pulmonary  220 (20)  67 (12)  153 (28) 
 Gastroenterology  96 (9)  62 (11)  34 (6) 
 Neurosurgery  99 (9)  57 (10)  42 (8) 
 General surgery  36 (3)  28 (5)  8 (1) 
 Orthopedics  21 (2)  14 (2)  7 (1) 
 Cardiology  12 (1)  5 (1)  7 (1) 
 Other  105 (10)  46 (9)  59 (11) 
Patient location 1100  550  550  
 Acute care  761 (69)  356 (65)  405 (74) 
 Critical care  304 (28)  169 (31)  135 (24) 
 Other (eg, preoperative)  35 (3)  25 (4)  10 (2) 
Reason for PICC placement       
 Difficult access 1100 137 (12) 550 82 (15) 550 55 (10) 
 Durable access 1100 329 (30) 550 181 (33) 550 148 (27) 
 Frequent laboratory draws 1100 151 (14) 550 84 (15) 550 67 (12) 
 Prolonged antibiotic course 1100 611 (56) 550 254 (46) 550 357 (65) 
 Other reason 1100 45 (4) 550 33 (6) 550 12 (2) 
Number of lumens 1090  545  545  
 1  960 (88)  473 (87)  487 (89) 
 ≥2  130 (12)  72 (13)  58 (11) 
Operator type 1099  549  550  
 Physician  48 (4)  28 (5)  20 (4) 
 PA/NP  381 (35)  207 (38)  174 (32) 
 RN  670 (61)  314 (57)  356 (64) 
PICC insertion site/vessel 1091  544  547  
 Basilic  593 (54)  292 (54)  301 (55) 
 Brachial  177 (16)  83 (15)  94 (17) 
 Cephalic  106 (10)  49 (9)  57 (11) 
 Femoral  132 (12)  78 (14)  54 (10) 
 Other insertion site  83 (8)  42 (8)  41 (7) 
Number of attempts 1093  546  547  
 1  886 (81)  454 (83)  432 (79) 
 2  127 (12)  59 (11)  68 (13) 
 3  58 (5)  24 (4)  34 (6) 
 >3  22 (2)  9 (2)  13 (2) 
PICC used for blood draws? 695a 555 (80) 367 279 (76) 328 276 (84) 
Reason for removal 1096  549  547  
 No longer medically necessary  1009 (92)  494 (90)  515 (94) 
 Complications  70 (6)  41 (8)  29 (5) 
 Other reason  17 (2)  14 (2)  3 (<1) 

Eval, evaluation; NP, nurse practitioner; PA, physician assistant; RN, registered nurse.

a

Data regarding blood draws only available from 3 sites.

Catheter Characteristics and Associated Complications

The majority of PICCs were placed by nurses (61%) and advance practice providers (35%). Eighty-eight percent of PICCs had a single lumen (Table 2). Ninety-two percent of PICCs stayed in place until completion of therapy; 6% were removed because of a catheter-associated complication. Rate of CLABSI in this cohort was 1% (n = 10) and rate of VTE was 1% (n = 13) (Table 3). The most common complication was catheter dislodgement (3%, n = 29), with 26 of 29 being removed by the patient. Concern for CLABSI was common in both the inappropriate and uncertain appropriateness groups, with a total of 184 catheters (17%) having at least 1 blood culture drawn while the catheter was in place.

TABLE 3

PICC-Related Complications

Combined, N = 1100Inappropriate Group, N = 550Uncertain Appropriateness Group, N = 550
N EvalN (%)N EvalN (%)N EvalN (%)
VTE 1100 13 (1) 550 5 (1) 550 8 (2) 
CLABSI 1100 10 (1) 550 5 (1) 550 5 (1) 
Infiltration/extravasation 1100 1 (<1) 550 0 (0) 550 1 (<1) 
Dislodgement 1100 29 (3) 550 22 (4) 550 7 (1) 
Phlebitis 1100 3 (<1) 550 1 (<1) 550 2 (<1) 
Occlusion 1100 21 (2) 550 12 (2) 550 9 (2) 
Line dysfunction/fracture 1100 11 (1) 550 7 (1) 550 4 (1) 
Concern for VTE 1100 33 (3) 550 18 (3) 550 15 (3) 
Concern for CLABSI 1100 184 (17) 550 66 (12) 550 118 (22) 
Combined, N = 1100Inappropriate Group, N = 550Uncertain Appropriateness Group, N = 550
N EvalN (%)N EvalN (%)N EvalN (%)
VTE 1100 13 (1) 550 5 (1) 550 8 (2) 
CLABSI 1100 10 (1) 550 5 (1) 550 5 (1) 
Infiltration/extravasation 1100 1 (<1) 550 0 (0) 550 1 (<1) 
Dislodgement 1100 29 (3) 550 22 (4) 550 7 (1) 
Phlebitis 1100 3 (<1) 550 1 (<1) 550 2 (<1) 
Occlusion 1100 21 (2) 550 12 (2) 550 9 (2) 
Line dysfunction/fracture 1100 11 (1) 550 7 (1) 550 4 (1) 
Concern for VTE 1100 33 (3) 550 18 (3) 550 15 (3) 
Concern for CLABSI 1100 184 (17) 550 66 (12) 550 118 (22) 

This multisite, retrospective study confirms a common concern regarding the inappropriate use of PICCs in hospitalized children. The study quantifies the rate of appropriate, uncertain appropriateness, and inappropriate use of PICCs at 4 children’s hospitals in the United States, according to widely accepted international guidelines published in 2020.5,6  Our findings suggest that the overall rate of PICC use from 2019 to 2021 is trending down (5.9% to 5.2%), which is likely multifactorial in nature (eg, evidence supporting shorter IV antibiotic courses for pediatric infections, local initiatives to reduce catheter-associated complications). However, up to 20% of PICCs placed each year do not meet criteria for appropriateness per the miniMAGIC recommendations. We did not find a statistically significant decrease in use of inappropriate PICC after the miniMAGIC guideline publication in June 2020. Per the guideline, peripheral catheters such as midline catheters or long peripheral catheters are more appropriate choices if anticipated length of therapy is ≤14 days for peripherally compatible infusates.6  During the US hospitalization peak of the corona disease 2019 pandemic (2020), the rate of PICC use was the highest of the 3 years included because of the lower number of total hospital encounters, the denominator (Fig 2A). The reason for the higher rate is unclear, but it’s likely multifactorial; it may be related to potentially higher acuity in the patients hospitalized during 2020 and other system-level changes (eg, staffing models, workforce configuration, infection prevention).

Similar to adult studies,14  the most common reason for placing a PICC of uncertain or inappropriate indications was prolonged antibiotic courses. Therefore, local or national quality initiatives should target this population specifically. For infections that require ≤14 days of IV antibiotics, a midline catheter or long peripheral catheter could be considered as an alternative to a PICC, even if the initial catheters may need to be replaced to complete therapy.6,15,16  Midline catheters were found to be safe and reliable alternatives to PICCs for prolonged IV antibiotic therapy in children with cystic fibrosis.16  However, future effectiveness and implementation studies should further evaluate the introduction of midline catheters as an alternative to PICCs in general hospitalized pediatric patients. In addition, using a PICC for prolonged IV antibiotic therapy in pediatric infections such as complicated pneumonia, complicated appendicitis, and bone/joint infections is considered low-value care by clinicians and researchers in the field.1720  Yet, 2 of the most common reasons for PICC placement for prolonged antibiotic courses in the general pediatrics population were treatment of pneumonia and bone/joint infections. The decision to place a PICC in children with complicated infections is likely compounded by need for frequent laboratory draws, reducing the number of pokes for the patient. In our study, 80% of PICCs were used for blood draws at least once.

Our study also identified significant variation in appropriateness between the 4 participating sites. The driver of this variation is not clear. Potential contributors to appropriate use of PICCs may be related to available vascular access resources, as noted in previous studies.21,22  For example, the site with the highest percentage of appropriate PICCs (site 1) has resources such as a vascular access team, ability to place midline catheters or long peripheral catheters, and the use of a catheter selection guide. In contrast, 2 of the other sites (including site 4), lack a catheter selection guide but they do have the other 2 resources available. None of the sites had implemented the miniMAGIC guideline at the time of the study. More research is needed to identify the barriers and facilitators that drive appropriate use of PICCs in pediatrics. In adult studies, the use of long peripheral catheters or midline catheters and a catheter selection guide decreased the use of inappropriate PICCs and, therefore, central catheter-associated complications.2327 

Overall, our data show that clinicians are appropriately selecting mostly single lumen PICCs, considering rate of CLABSI increases with each increase in number of lumens28 ; however, more opportunities to decrease multilumen PICC use exist. In our study, 12% (n = 130) of PICCs had 2 or more lumens even when the majority of patients were outside of the ICU (72%) and all received medications that were peripherally compatible. Regarding PICC placement, we found that 19% of PICCs (n = 207) required >1 attempt for successful placement, with 7% requiring 3 or more attempts. Rates of CLABSI and VTE were lower in our population compared with other populations or pooled data from systematic reviews and meta-analysis.4  This is an important finding to consider when balancing the risks and benefits of selecting a PICC. Our population was primarily hospitalized on the acute care floor, so patients likely had fewer additional risk factors for developing CLABSI or VTE (eg, severity of illness).29,30  We were unable to reliably look at trends of CLABSI and VTE over the study period because of the small number of complications overall; this is similar to published adult studies led by Chopra et al.31,32  In addition to the harm to patients, the cost of 1 CLABSI and 1 VTE episode is estimated to be $55 646 and $27 686, respectively.33,34  The use of resources needed to monitor for these complications add additional cost. In our study, blood cultures were obtained in 17% of the cases, whereas catheter in place (184 catheters) and ultrasound of extremity were obtained in 3% of the cases (33 catheters). The ultrasounds were always completed to assess for PICC-associated VTE development; however, it was not clear if the blood cultures were obtained because of concern for CLABSI or because of concern for bacteremia secondary to presenting illness.

Our study has a few limitations related to the retrospective nature of the study design and reliance on EMR documentation. When dividing the PICCs into the 3 groups (appropriate, inappropriate, uncertain), assumptions were made that the PICCs were nonurgently placed and were not used for central venous monitoring, both being difficult to gauge from the EMR documentation, but both situations would have made those PICCs appropriate. Need for frequent laboratory draws or difficulty obtaining IV access are sometimes reasons for placing an appropriate PICC. Similarly, a patient who is stable versus unstable in the ICU settings may have different vascular access needs, and the miniMAGIC has specific recommendations for this specialized population. Because this information is not consistently documented in the EMR, we chose not to incorporate it in our definition of appropriateness. The primary criteria devising the 3 appropriateness groups was dwell time of ≤7 days, 8 to 14 days, and >14 days. We recognize that, in some cases, the PICCs were removed before completion of therapy because of a complication, having shorter dwell time than originally anticipated. Those cases may have been otherwise appropriate. To work with this limitation, we examined trends and variation between sites after removing the complication cases. To maintain consistency in measures collected from the EMR and to allow for data harmonization, we used predetermined definitions; however, this strategy may have missed infections less commonly encountered or cases of multiple infections (eg, pneumonia and bacteremia). In addition, we only performed chart review to confirm inclusion/exclusion criteria and to collect more detailed data for the inappropriate and uncertain appropriateness groups, so we assumed that the remaining of the PICCs would, by the process of elimination, be appropriate. Because data from all 4 sites were harmonized after they were deidentified, we were not able to determine the number of patients with >1 encounter with a PICC during the study period. Additional catheter-associated complications (eg, infiltration, occlusion, dislodgment) can only be identified on the basis of EMR, so the rates described in our study may be an underestimate because documentation is sometimes lacking or incomplete. Finally, all participating sites are standalone teaching hospitals and the pattern of PICC use may not accurately describe that of a community-based hospital.

The use of PICCs has decreased over the past few years, but up to 20% of catheters each year are still not appropriately placed per the miniMAGIC. PICCs that are inappropriate or of uncertain appropriateness are more likely to be used for prolonged IV antibiotics and safe alternatives are available to support this administration. Thus, this population may be a target for future improvement efforts.

Dr Burek conceptualized and designed the study, led data collection, analysis and interpretation, and drafted and revised the manuscript; Ms Davis, Ms Pechous, and Ms Woodruff, Drs Shaughnessy, Meier, Mooney, Bruner, and Piper contributed to the design of the study, completed data collection, participated in data analysis and interpretation, and critically reviewed and revised the manuscript; Dr Pan and Ms Liegl contributed to study design, performed the quantitative statistical analysis, and reviewed and revised the manuscript; Drs Ullman and Brousseau contributed to the conceptualization and the study design, reviewed the data analysis plan and data output, and critically reviewed and revised the manuscript; and all authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work.

FUNDING: Dr Burek’s work on this study was in part completed while participating in a 2-year clinical research scholar program funded by a NIH training grant (UL1 TR001436). The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding organizations. The funding organizations had no role in the design or conduct of this study.

CONFLICT OF INTEREST DISCLOSURES: Dr Ullman’s employer (The University of Queensland) has received investigator-initiated research grants from vascular access product manufacturers (3M, Becton Dickinson, Medline) on behalf of her research, unrelated to the submitted project. Dr Brousseau receives consultancy funding from CSL Behring unrelated to this work. The remaining authors have indicated they have no conflicts of interest relevant to this article to disclose.

1
Paterson
RS
,
Chopra
V
,
Brown
E
, et al
.
Selection and insertion of vascular access devices in pediatrics: a systematic review
.
Pediatrics
.
2020
;
145
(
Suppl 3
):
S243
S268
2
Gibson
C
,
Connolly
BL
,
Moineddin
R
,
Mahant
S
,
Filipescu
D
,
Amaral
JG
.
Peripherally inserted central catheters: use at a tertiary care pediatric center
.
J Vasc Interv Radiol
.
2013
;
24
(
9
):
1323
1331
3
Burek
AG
,
Parker
J
,
Bentzien
R
,
Talbert
L
,
Havas
M
,
Hanson
SJ
.
The development of a long peripheral catheter program at a large pediatric academic center: a pilot study
.
Hosp Pediatr
.
2020
;
10
(
10
):
897
901
4
Ullman
AJ
,
Marsh
N
,
Mihala
G
,
Cooke
M
,
Rickard
CM
.
Complications of central venous access devices: a systematic review
.
Pediatrics
.
2015
;
136
(
5
):
e1331
e1344
5
Ullman
AJ
,
Chopra
V
,
Brown
E
, et al
.
Developing appropriateness criteria for pediatric vascular access
.
Pediatrics
.
2020
;
145
(
Suppl 3
):
S233
S242
6
Ullman
AJ
,
Bernstein
SJ
,
Brown
E
, et al
.
The Michigan appropriateness guide for intravenous catheters in pediatrics: miniMAGIC
.
Pediatrics
.
2020
;
145
(
Suppl 3
):
S269
S284
7
Ullman
A
,
Chopra
V
.
Developing pediatric appropriateness criteria for intravenous catheters
.
Pediatrics
.
2020
;
145
(
Suppl 3
):
S231
S233
8
von Elm
E
,
Altman
DG
,
Egger
M
,
Pocock
SJ
,
Gøtzsche
PC
,
Vandenbroucke
JP
.
STROBE Initiative
.
The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies
.
Int J Surg
.
2014
;
12
(
12
):
1495
1499
9
Schults
J
,
Kleidon
T
,
Chopra
V
, et al
.
International recommendations for a vascular access minimum data set: a Delphi consensus-building study
.
BMJ Qual Saf
.
2021
;
30
(
9
):
722
730
10
Ullman
AJ
,
Gibson
V
,
Takashima
MD
, et al
.
Pediatric central venous access devices: practice, performance, and costs
.
Pediatr Res
.
2022
;
92
(
5
):
1381
1390
11
Govindan
S
,
Snyder
A
,
Flanders
SA
,
Chopra
V
.
Peripherally inserted central catheters in the ICU: a retrospective study of adult medical patients in 52 hospitals
.
Crit Care Med
.
2018
;
46
(
12
):
e1136
e1144
12
Centers for Disease Control and Prevention
.
National Healthcare Safety Network (NHSN)
. Available at: www.cdc.gov/nhsn. Accessed February 18, 2022
13
R Core Team
.
R: a language and environment for statistical computing
. Available at: https://www.R-project.org/. Accessed April 12, 2023
14
Swaminathan
L
,
Flanders
S
,
Horowitz
J
,
Zhang
Q
,
O’Malley
M
,
Chopra
V
.
Safety and outcomes of midline catheters vs peripherally inserted central catheters for patients with short-term indications: a multicenter study
.
JAMA Intern Med
.
2022
;
182
(
1
):
50
58
15
Burek
AG
,
Liljestrom
T
,
Dundon
M
,
Shaughnessy
EE
,
Suelzer
E
,
Ullman
A
.
Long peripheral catheters in children: a scoping review
.
J Hosp Med
.
2022
;
17
(
12
):
1000
1009
16
Kleidon
TM
,
Schults
JA
,
Wainwright
C
, et al
.
Comparison of midline catheters and peripherally inserted central catheters to reduce the need for general anesthesia in children with respiratory disease: a feasibility randomized controlled trial
.
Paediatr Anaesth
.
2021
;
31
(
9
):
985
995
17
House
SA
,
Hall
M
,
Ralston
SL
, et al
.
Development and use of a calculator to measure pediatric low-value care delivered in US children’s hospitals
.
JAMA Netw Open
.
2021
;
4
(
12
):
e2135184
18
Rangel
SJ
,
Anderson
BR
,
Srivastava
R
, et al
.
Pediatric Research in Inpatient Settings (PRIS) Network
.
Intravenous versus oral antibiotics for the prevention of treatment failure in children with complicated appendicitis: has the abandonment of peripherally inserted catheters been justified?
Ann Surg
.
2017
;
266
(
2
):
361
368
19
Keren
R
,
Shah
SS
,
Srivastava
R
, et al
.
Pediatric Research in Inpatient Settings Network
.
Comparative effectiveness of intravenous vs oral antibiotics for postdischarge treatment of acute osteomyelitis in children
.
JAMA Pediatr
.
2015
;
169
(
2
):
120
128
20
Shah
SS
,
Srivastava
R
,
Wu
S
, et al
.
Pediatric Research in Inpatient Settings Network
.
Intravenous versus oral antibiotics for postdischarge treatment of complicated pneumonia
.
Pediatrics
.
2016
;
138
(
6
):
e20161692
21
Davis
MBH
,
Takashima
M
,
Girgenti
C
,
Ullman
AJ
.
An international survey of pediatric and neonatal clinicians’ vascular access practice: PediSIG assessment of vascular access, education, and support (PAVES) catheter selection
.
Br J Nurs
.
2020
;
29
(
14
):
S40
S48
22
Cortés Rey
N
,
Pinelli
F
,
van Loon
FHJ
, et al
.
The state of vascular access teams: results of a European survey
.
Int J Clin Pract
.
2021
;
75
(
12
):
e14849
23
Pernar
LIM
,
Wolf
LL
,
Seshadri
A
,
Patel
V
.
Impact of a surgeon-led peripherally inserted central venous catheter team on peripherally inserted central venous catheter-related complications and costs
.
Surg Infect (Larchmt)
.
2016
;
17
(
3
):
352
356
24
DeVries
M
,
Lee
J
,
Hoffman
L
.
Infection free midline catheter implementation at a community hospital (2 years)
.
Am J Infect Control
.
2019
;
47
(
9
):
1118
1121
25
Moureau
N
,
Sigl
G
,
Hill
M
.
How to establish an effective midline program: a case study of 2 hospitals
.
J Assoc Vasc Access
.
2015
;
20
(
3
):
179
188
26
Bourgeois
FC
,
Lamagna
P
,
Chiang
VW
.
Peripherally inserted central catheters
.
Pediatr Emerg Care
.
2011
;
27
(
6
):
556
561, quiz 562–563
27
Swaminathan
L
,
Flanders
S
,
Rogers
M
, et al
.
Improving PICC use and outcomes in hospitalized patients: an interrupted time series study using MAGIC criteria
.
BMJ Qual Saf
.
2018
;
27
(
4
):
271
278
28
Chopra
V
,
Ratz
D
,
Kuhn
L
,
Lopus
T
,
Chenoweth
C
,
Krein
S
.
PICC-associated bloodstream infections: prevalence, patterns, and predictors
.
Am J Med
.
2014
;
127
(
4
):
319
328
29
Moriyama
K
,
Ando
T
,
Kotani
M
, et al
.
Risk factors associated with increased incidences of catheter-related bloodstream infection
.
Medicine (Baltimore)
.
2022
;
101
(
42
):
e31160
30
Chopra
V
,
Kaatz
S
,
Conlon
A
, et al
.
The Michigan Risk Score to predict peripherally inserted central catheter-associated thrombosis
.
J Thromb Haemost
.
2017
;
15
(
10
):
1951
1962
31
Chopra
V
,
O’Malley
M
,
Horowitz
J
, et al
.
Improving peripherally inserted central catheter appropriateness and reducing device-related complications: a quasiexperimental study in 52 Michigan hospitals
.
BMJ Qual Saf
.
2022
;
31
(
1
):
23
30
32
Bredenberg
E
,
Atwater
R
,
Grimm
E
,
Chopra
V
,
Dale Shamburger
C
,
Anstett
TJ
.
Promoting appropriate midline catheter and PICC placement through implementation of an EHR-based clinical decision support tool: an interrupted time-series analysis
.
J Hosp Med
.
2023
;
18
(
6
):
483
490
33
Goudie
A
,
Dynan
L
,
Brady
PW
,
Fieldston
E
,
Brilli
RJ
,
Walsh
KE
.
Costs of venous thromboembolism, catheter-associated urinary tract infection, and pressure ulcer
.
Pediatrics
.
2015
;
136
(
3
):
432
439
34
Goudie
A
,
Dynan
L
,
Brady
PW
,
Rettiganti
M
.
Attributable cost and length of stay for central line-associated bloodstream infections
.
Pediatrics
.
2014
;
133
(
6
):
e1525
e1532